Latest Tissue plasminogen activator Stories
Women with clot-caused strokes are less likely than men to arrive at the hospital in time to receive the best treatment.
A new study from the University of Cincinnati (UC) College of Medicine has found that, when delivered via ultrasound, the natural enzyme plasmin is more effective at dissolving stroke-causing clots than the standard of care, recombinant tissue plasminogen activator (rt-PA).
Award demonstrates the New York Hospital's commitment to quality care for stroke patients. Mt.
Stroke patients are three times more likely to receive clot-busting medication if treated at a certified stroke center.
When someone has a stroke, time equals brain.
Millions of Americans take aspirin or other drugs every day to reduce their risk of heart attacks or other problems caused by blood clots.
NeuroCareTech introduces First iPhone app designed by a doctor for doctors’ clinical use to help rapidly determine stroke patient eligibility for life-saving treatment called tPA.